Plain-English translation of NCT07388550 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
United States
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Enrollment target
~15 participants
Started
June 2026
Primary completion
January 2028
Age range
18 Years – 110 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ladifatou N Fouanta, R.N.
National Institute of Neurological Disorders and Stroke (NINDS)
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.